| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.08 | 0.2 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.2 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |